OPKO Health, Inc. Common Stock, Capital Shares Reserved for Future Issuance
OPKO Health, Inc. (OPK) had Common Stock, Capital Shares Reserved for Future Issuance of 19.15 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-26
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 19.15M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 28.87M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 32.90T shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.68M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 19.15M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 28.87M shares 10-K · filed 2025-03-03 |
| 2023-12-31 | 32.90T shares 10-K · filed 2024-03-01 |
| 2022-12-31 | 8.68M shares 10-K · filed 2023-02-27 |
| 2021-12-31 | 11.56M shares 10-K · filed 2022-03-01 |
| 2020-12-31 | 20.88M shares 10-K · filed 2021-02-18 |
| 2019-12-31 | 22.30M shares 10-K · filed 2020-03-02 |
| 2018-12-31 | 26.67M shares 10-K · filed 2019-03-01 |
| 2017-12-31 | 28.90M shares 8-K · filed 2019-01-29 |
| 2016-12-31 | 26.87M shares 10-K · filed 2017-03-01 |
| 2015-12-31 | 2.06M shares 10-K · filed 2016-02-29 |
| 2014-12-31 | 16.74M shares 10-K · filed 2015-02-27 |
| 2013-12-31 | 21.40M shares 10-K · filed 2014-03-03 |
| 2012-12-31 | 6.63M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |